CON vs the Top Picks average
| Pillar | CON | Book avg | Diff |
|---|---|---|---|
| Quality | 0.74 | 0.84 | -0.10 |
| Growth | 0.82 | 0.84 | in line |
| Value | 0.55 | 0.78 | -0.24 |
Averaged across the 30 names in today's Top Picks (mean score 81.5). A name can beat these averages and still be absent from the book — it also applies concentration limits.
One point per daily model run. The range autoscales, so a flat-looking line can still hide 1–2 point moves — read the From → To values for the actual range.
Analyst estimate revisions
| 30-day change | +8.3% |
|---|---|
| 90-day change | +7.6% |
| Forward EPS estimate | $1.83 |
Over the last 90 days, what analysts expect CON to earn is materially higher (+7.6%). The estimate is derived from price and forward P/E captured at the same instant, so a moving share price does not move this number — only a changed forecast does.
A rising estimate means expectations are improving, not that the price has failed to keep up — and estimates get cut as readily as they get raised. It is not part of the Bull Rankings score. Biggest movers across the market →
Math only — share count is floor(portfolio × risk% ÷ (price × stop%)). Doesn't account for commissions, slippage, gap risk, or position-correlation across your book. Inputs persist locally; never sent to the server. Not investment advice.
Latest CON developments
Recent headlines from across the financial press · updated daily. Links open the source.
- Concentra Group Holdings Parent (CON) Is Up 7.6% After Raising 2026 Guidance And Detailing CEO Succession – Has The Bull Case Changed?Yahoo ·
- Wells Fargo Maintains Overweight on Concentra Group Holdings, Raises Price Target to $40Benzinga ·
- Concentra Poised to Benefit From AI Data Center Development, RBC SaysYahoo ·
- CON or MEDP: Which Is the Better Value Stock Right Now?Yahoo ·
- Truist Securities Maintains Buy on Concentra Group Holdings, Raises Price Target to $42Benzinga ·
- Concentra to Present at Upcoming Investor ConferencesYahoo ·
Concentra Group Holdings Parent, Inc. (CON): score, valuation & FAQ
Concentra Group Holdings Parent, Inc. (CON) is a Medical Care Facilities company that scores 69.3 out of 100 on the Bull Rankings quality-growth model — a solid, above-average reading. The score blends three pillars — quality (durable returns, healthy margins, low leverage), growth (revenue and earnings), and value (valuation versus sector peers) — into one number, refreshed daily; it is a screen, not a buy recommendation.
Its strongest graded signals are Rev (B+) and P/E (B+), while D/E (D) rate weaker. On valuation, CON sits about 35% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -2% annual free-cash-flow growth over the next decade.
Is CON a good stock to buy?
Bull Rankings scores CON 69.3 out of 100 on its quality-growth model, which is a solid, above-average reading. That is driven by Rev (B+) and P/E (B+). A score is a quantitative screen of Concentra Group Holdings Parent, Inc.'s fundamentals, not personalised financial advice — weigh it against your own time horizon and risk tolerance, and read the risk factors below before acting.
Why does CON score 69.3 on Bull Rankings?
The quality-growth score blends three pillars — quality (returns on capital, margins, leverage, earnings quality), growth (revenue and earnings expansion), and value (valuation versus sector peers). CON earns its highest marks on Rev (B+) and P/E (B+), and is held back by D/E (D). Each pillar is graded against sector-aware thresholds, then combined into the single 0–100 score.
Is CON overvalued or undervalued?
Based on $35.00, CON sits about 35% below our discounted-cash-flow fair value (a margin of safety) — the current price implies roughly -2% annual free-cash-flow growth over the next decade. It trades at a 22.6x P/E (graded B+). Discounted-cash-flow estimates are sensitive to growth and discount-rate assumptions, so treat this as a cross-check, not a price target.
What are the main risks of investing in CON?
Bears point to the balance sheet – a debt‑to‑equity of 4.68 and a reverse‑DCF that forces a -5% annual free‑cash‑flow growth assumption, a stark contrast to the 14% revenue climb. If debt service pressures force cap‑ex cuts or margin compression, the high PE of 22 looks stretched and the growth story unravels. A sustained dip in on‑site clinic utilization would confirm the downside.
New to these metrics? The guides explain free cash flow, how the score works, and more in the learn hub — or run another name through the screener.
Bull Rankings is an automated fundamentals screen for research and education. It is not investment advice, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a licensed financial advisor.